
    
      Participants will all get sacroiliac joint fusion on this study using the iFuse-3D titanium
      implant, manufactured by SI-BONE, Inc. Participants will be followed for clinical outcomes at
      pre-planned time points on the trial. Participants will be randomized to CT scan at 6 months
      or 12 months, and all will also get a CT scan at 5 years, the final visit for the study.
    
  